跳至主要内容
临床试验/CTRI/2022/12/048127
CTRI/2022/12/048127尚未招募4 期

A prospective analytical study on the efficacy of oral Rebamipide vs intralesional Triamcinolone + Hyaluronidase injection for the treatment of oral submucous fibrosis in a tertiary care hospital. - OSMF

Osmania Medical College0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with OSMF with stomatopyrosis and/or grade 1 or 2 trismus
  • Patients willing to take intralesional Triamcinolone + Hyaluronidase
  • Patients willing to take oral Rebamipide tablets
  • Patients willing to abstain from smoking/betel nut chewing (if addicted)

排除标准

  • Patients not willing for follow up
  • Patients with diagnosed oral malignancy
  • Patients with grade 3 trismus or above

研究者

相似试验